Records containing: Stage II Adult Soft Tissue Sarcoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-06-09A Pilot Study Investigating ¹⁸F-FLT-PET as a Marker of Response to Preoperative Radiotherapy in Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2017-11-17A Phase 2 Study of Positron Emission Tomography Imaging With [18F]-Fluoromisonidazole (FMISO) and [18F]-Fluorodeoxyglucose (FDG) for Assessment of Tumor Hypoxia in Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2017-10-06Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age
-
CLINICAL_TRIALS study record update · 2014-03-17A Phase II Clinical and Correlative Study of BAY 43-9006 (Sorafenib) IND 69,896 in Sarcoma
-
CLINICAL_TRIALS study record update · 2013-06-17Randomized Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine, Topotecan and Cyclophosphamide for Patients With Intermediate Risk Rhabdomyosarcoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-06-04A Trial of CCI-779 in Patients With Soft Tissue Sarcoma.
-
CLINICAL_TRIALS study record update · 2013-01-16Does Hypoxia Predict Radiation/Surgical Tumor Response/A Correlative Trial of EF5, an Agent for the Detection of Tumor Hypoxia
-
CLINICAL_TRIALS study record update · 2013-01-16Distribution Of The Photosensitizer Motexafin Lutetium And Hypoxia In Patients With Malignancies